Skip to main content

Nonprofit · EIN 20-3674498

GLOBAL HEALTH SOLUTIONS INC

Tax-exempt · DECATUR, GA 30030

Financials

$628.8M$628.8M2022$511.5M$511.5M2023$772M$772M2024
Revenue Expenses · by fiscal year end
Financials of GLOBAL HEALTH SOLUTIONS INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
August 31, 2025990$772,045,614$772,045,614$0$0$0$0
August 31, 2024990$511,468,181$511,468,181$0$0$0$0
August 31, 2023990$628,809,066$628,809,066$0$0$0$0
Financial details: 990 for the year ended August 31, 2025

Revenue

Contributions, gifts and grants
$772,045,614
Program service revenue
$0
Investment income
$0
Other revenue
$0

Expenses

Grants and similar amounts paid
$772,045,614
Compensation of officers, directors and key employees
$0
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Program services (functional)
$772,045,614

Balance sheet and other

Total assets, start of year
$0
Total assets, end of year
$0
Total liabilities, end of year
$0
Net assets, end of year
$0
Gross receipts
$772,045,614
Employees
0
Volunteers
0
Year formed
2005
State of legal domicile
GA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended August 31, 2025, highest compensation first.

NameTitleHours / weekCompensationFrom related orgs
Patrick O'CarrollChairman
Officer
1$0$397,023
Mark McKinlayOfficer
Former
0$0$245,812
Ellen WildTreasurer
Officer
1$0$237,534
Daniel N MartinsSecretary
Officer
1$0$228,252
Nancy KnightOfficer
Officer
1$0$198,758
990 for the year ended August 31, 2024: 5 people
NameTitleHours / weekCompensationFrom related orgs
Patrick O'CarrollChairman
Trustee or director
1$0$411,644
Mark McKinlayOfficer
Officer, Former
1$0$387,309
William P NicholsOfficer
Officer, Former
1$0$339,114
Daniel N MartinsSecretary
Officer
1$0$253,744
Ellen WildTreasurer
Officer
1$0$227,921
990 for the year ended August 31, 2023: 5 people
NameTitleHours / weekCompensationOther / benefits
David A RossChairman
Former
1$0$417,725
Patrick O'CarrollChairman
Officer
1$0$357,404
Mark McKinlayOfficer
Officer
1$0$341,085
William P NicholsTreasurer
Officer
1$0$322,266
Ellen WildOfficer
Officer
1$0$206,634

Address and contacts

Address (IRS master file)
330 W PONCE DE LEON AVE, DECATUR, GA 30030-2439
Principal officer (990 for 2024)
Patrick O'Carroll, 330 Ponce de Leon Avenue, Decatur, GA 30030
Signed the 990
Ellen Wild, Chief Operating Officer
Phone
(404) 592-1430

Mission

As a supporting organization, support the global health efforts of The Task Force for Global Health, Inc. by principally receiving donated phamaceuticals and coordinating the shipment to designated countries for the treatment of blinding trachoma, river blindness and vaccine preventable diseases.

990 for the year ended August 31, 2025

Program accomplishments

  • The International Trachoma Initiative (ITI) works tirelessly for a world free from trachoma. ITI contributes to eliminating trachoma as a public health threat by stewarding Pfizer's donation of azithromycin to treat and prevent the condition; building and strengthening partnerships to accelerate progress; and developing innovative tools to share data. Between September 2024 and August 2025, ITI organized just-in-time shipments of 44.6 million treatments for trachoma to be distributed at MDAs in 12 countries. As of August 2025, ITI has shipped more than 1.117 billion treatments to trachoma-endemic countries since the program's inception in 1999. ITI continued its data management support for Tropical Data, a free mobile phone-based service to support trachoma programs as they conduct prevalence surveys, providing them with robust data for decision-making on where antibiotic treatments are needed and where they can be stopped. Since its inception in February 2016, Tropical Data has supported over 4,136 surveys across 55 countries. As a key player in the global trachoma community, there have been tremendous achievements in reducing the population at risk of blindness from trachoma from an estimated 1.5 billion people in 2002 to 97.1 million in November 2025 according to the World Health Organization (WHO). ITI will continue to work smarter so that the dream of a trachoma-free world becomes a reality. In addition to ITI's work in trachoma, ITI was awarded a grant from the Gates Foundation in August 2024 to expand into the donation of azithromycin for child survival. Between September 2024 and August 2025, ITI organized just-in-time shipments of 22.8 million treatments for child survival to be distributed at MDAs in 3 countries.
    Expenses $758,274,549 · grants $758,274,549 · revenue $758,274,549
  • Mectizan Donation Program In 2025, 349.1 million treatments were approved for mass drug administration (MDA) for onchocerciasis and lymphatic filariasis (LF) elimination in 36 countries and territories. The breakdown of treatments approved is as follows: 1) 240.9 million for onchocerciasis only including 30.6 million treatments approved to implement a second round of treatment in 8 countries (Brazil, Burkina Faso, DRC, Ethiopia, Malawi, Togo, Uganda and Venezuela). 2) 29.9 million for onchocerciasis & LF co-endemic communities. 3) 78.3 million for LF only, of which 51.4 million were approved for 11 countries and territories implementing triple therapy with ivermectin, DEC, and albendazole (IDA). The number of treatments approved in 2025 decreased compared with previous years. This decline is not only attributable to the downscaling of the LF programme, but also to the decision to implement only a single treatment round for onchocerciasis instead of two in Ghana, Tanzania, and Togo, following USAID-NTD funding cuts and a missed campaign in Mozambique and Angola. 2025, total shipments were down to 737.6 million tablets. This decrease was driven not only by the large number of tablets remaining in inventory after the 2024 annual mass drug administrations (MDAs) in countries (138.4 million tablets), but also by the deferral to 2026 of 179.7 million tablets originally scheduled for shipment in 2025 due to operational challenges in Nigeria, the Democratic Republic of the Congo, Mali, Sudan, and the Philippines By the end of 2025, cumulative shipments of Mectizan 3 mg tablets reached 14.66 billion, representing 5.23 billion treatments since the programme began in 1987. The milestone of 5 billion treatments was celebrated throughout the year.
    Expenses $13,771,065 · grants $13,771,065 · revenue $13,771,065

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in August, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025August 31, 2026January 15, 2027Not due yet
2024August 31, 2025January 15, 2026990 on file
2023August 31, 2024January 15, 2025990 on file

IRS record

EIN
20-3674498
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Supporting organization (509(a)(3))
Donations deductible (Pub 78)
Supporting organization of unknown type
Exempt since
2005
Accounting year ends
August
Files
Form 990 or 990-EZ
Category (NTEE)
Health care (E11)
Income (IRS master file)
$772,045,614

Filing history

FormYear endedRevenueExpensesAssetsReturn
990August 2025$772,045,614$772,045,614$0XML
990August 2024$511,468,181$511,468,181$0XML
990August 2023$628,809,066$628,809,066$0XML
990August 2022$632,371,996$632,371,996$0IRS
990August 2021–––IRS
990August 2020–––IRS
990August 2019–––IRS
990August 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 20-3674498).

Questions about GLOBAL HEALTH SOLUTIONS INC

What is the EIN of GLOBAL HEALTH SOLUTIONS INC?
The employer identification number (EIN) of GLOBAL HEALTH SOLUTIONS INC is 20-3674498.
Is GLOBAL HEALTH SOLUTIONS INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2005.
Are donations to GLOBAL HEALTH SOLUTIONS INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Supporting organization of unknown type).
Which annual return does GLOBAL HEALTH SOLUTIONS INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of GLOBAL HEALTH SOLUTIONS INC due?
The return for tax year 2025 (the year ending August 31, 2026) is due January 15, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did GLOBAL HEALTH SOLUTIONS INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended August 2025.
Who is the principal officer of GLOBAL HEALTH SOLUTIONS INC?
The 990 for the year ended August 31, 2025 names Patrick O'Carroll.
Who are the officers and directors of GLOBAL HEALTH SOLUTIONS INC?
The 990 for the year ended August 31, 2025 lists 5 people; 0 received compensation from the organization.
How much revenue does GLOBAL HEALTH SOLUTIONS INC have?
On its 990 for the year ended August 31, 2025 it reported revenue of $772,045,614, expenses of $772,045,614 and total assets of $0 at year end.

Other nonprofits in DECATUR

All nonprofits in DECATUR · Georgia · Health care